Finance

Lists
Why is 300199 up 7.07%?
Dive Deeper
300199:SHE
Hybio Pharmaceutical Co Ltd
CNÂ¥22.71
+7.07%
(+1.50) 1D
Nov 4, 3:04:25 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300199...
Open
CNÂ¥21.09
High
CNÂ¥22.88
Low
CNÂ¥21.02
Mkt. cap
18.73B
Avg. vol.
51.23M
Volume
45.82M
P/E ratio
49.91
52-wk high
CNÂ¥27.70
52-wk low
CNÂ¥16.23
EPS
CNÂ¥0.45
Shares outstanding
883.24M
No. of employees
1K
Open
CNÂ¥21.09
High
CNÂ¥22.88
Low
CNÂ¥21.02
Mkt. cap
18.73B
Avg. vol.
51.23M
Volume
45.82M
P/E ratio
49.91
52-wk high
CNÂ¥27.70
52-wk low
CNÂ¥16.23
EPS
CNÂ¥0.45
Shares outstanding
883.24M
No. of employees
1K
News stories
From web sources and news partners
About Hybio Pharmaceutical Co Ltd
CEO-
Employees1.23K
Founded1998
Headquarters-
SectorPharmaceutical industry
Industry-
Websitehybio.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
283.23M
299.15M
389.14M
554.08M
Cost of goods sold
152.93M
105.01M
159.91M
172.20M
Cost of revenue
152.93M
105.01M
159.91M
172.20M
Research and development expenses
51.07M
30.87M
67.08M
62.98M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
59.40M
44.68M
41.35M
56.10M
Operating expense
121.55M
80.50M
111.54M
127.79M
Total operating expenses
274.48M
185.52M
271.45M
299.99M
Operating income
8.75M
113.63M
117.69M
254.09M
Other non operating income
-4.72M
-3.55M
-2.51M
-6.45M
EBT including unusual items
-23.38M
136.89M
116.86M
207.50M
EBT excluding unusual items
-21.32M
134.01M
112.37M
215.25M
Income tax expense
12.35M
9.50M
8.62M
7.96M
Effective tax rate
-52.81%
6.94%
7.37%
3.83%
Other operating expenses
4.18M
1.78M
3.82M
2.43M
Net income
-34.78M
127.81M
108.89M
199.94M
Net profit margin
-12.28%
42.73%
27.98%
36.09%
Earnings per share
-
-
-
-
Interest and investment income
-
224.45K
65.73M
-
Interest expense
-26.19M
-23.28M
-17.57M
-36.37M
Net interest expenses
-26.19M
-23.05M
48.15M
-36.37M
Depreciation and amortization charges
-
-
-
-
EBITDA
41.34M
146.22M
157.41M
286.68M
Gain or loss from assets sale
-617.19K
-
-1.59M
1.59M
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps